Header Logo

JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines.

JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines. Exp Hematol Oncol. 2012 Jun 21; 1(1):15.

View in: PubMed